Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund Regular-Growth
Equity
Sectoral-Pharma
₹-0.9% 1D
NAV on
Overview
Chart
Returns
Asset Allocation
Fund Info
Risk & Return Ratio
Fund Overview
- Rating
3 - Minimum Investment₹100
- NAV (Net Asset Value)₹N/A
- AUM (Fund size)₹196 Cr
- Created on1 Oct 2020
Fund Ranking
#15
/ 16 in Sectoral-Pharma
Risk Level
Very High
Very High
Loading...
Returns
Trailing Return
Rolling Return
- 6 Month12.9%
- 1 Year20.7%
- 3 Year (CAGR)19.2%
- All Time (CAGR)16.0%
Category Return
- 6 Month17.3%
- 1 Year16.6%
- 3 Year (CAGR)20.9%
- All Time (CAGR)17.1%
Asset Allocation
- Equity99.8%
- Debt0.1%
- Other0.1%
Top 5 Holdings
Top 5 Sectors
- Apollo Hospitals Enterprise5.71%
- Aurobindo Pharma2.70%
- Cipla4.84%
- Dr. Reddy's Laboratories4.44%
- Ipca Laboratories1.55%
Fund Information
- Expense Ratio1.10%
- Exit LoadNo Exit Load
- Lock-In PeriodNo Lock-In
Managed By
Manasi Jalgaonkar
April 2026 - Present
Risk & Return Ratio
- Sharpe Ratio
Sharpe Ratio evaluates a fund's return relative to its risk. Higher values signify better risk-adjusted performance. 1.10 - Standard Deviation
Standard deviation measures the volatility of a fund's returns. The higher the value, the riskier the investment. 12.17 - Alpha
Alpha in mutual funds measures excess return relative to a benchmark, indicating a manager's skill at generating returns beyond market performance. 2.20 - Beta
Beta in mutual funds indicates a fund's sensitivity to market changes. A beta over 1 means it's more volatile than the market, while below 1 implies less volatility. 0.66